These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29393902)

  • 1. Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells.
    Rosman R; Saifullah B; Maniam S; Dorniani D; Hussein MZ; Fakurazi S
    Nanomaterials (Basel); 2018 Feb; 8(2):. PubMed ID: 29393902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.
    Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME
    Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphene Oxide⁻PEG⁻Protocatechuic Acid Nanocomposite Formulation with Improved Anticancer Properties.
    Saifullah B; Buskaran K; Shaikh RB; Barahuie F; Fakurazi S; Mohd Moklas MA; Hussein MZ
    Nanomaterials (Basel); 2018 Oct; 8(10):. PubMed ID: 30314340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid.
    Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ
    Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sustained release study of gallic acid coated with magnetite-PEG and magnetite-PVA for drug delivery system.
    Dorniani D; Kura AU; Hussein-Al-Ali SH; Bin Hussein MZ; Fakurazi S; Shaari AH; Ahmad Z
    ScientificWorldJournal; 2014; 2014():416354. PubMed ID: 24737969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Fe₃O₄ magnetic nanoparticles coated with gallic acid for drug delivery.
    Dorniani D; Hussein MZ; Kura AU; Fakurazi S; Shaari AH; Ahmad Z
    Int J Nanomedicine; 2012; 7():5745-56. PubMed ID: 23166439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy.
    Dorniani D; Saifullah B; Barahuie F; Arulselvan P; Hussein MZ; Fakurazi S; Twyman LJ
    Nanoscale Res Lett; 2016 Dec; 11(1):491. PubMed ID: 27822913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.
    Huang W; Wang X; Shi C; Guo D; Xu G; Wang L; Bodman A; Luo J
    Mol Pharm; 2015 Apr; 12(4):1216-29. PubMed ID: 25692376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation.
    Ahmed HH; Galal AF; Shalby AB; Abd-Rabou AA; Mehaya FM
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3137-3146. PubMed ID: 30486601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulating co-loaded nanoliposomes with gallic acid and quercetin for enhanced cancer therapy.
    Al-Samydai A; Al Qaraleh M; Al Azzam KM; Mayyas A; Nsairat H; Abu Hajleh MN; Al-Halaseh LK; Al-Karablieh N; Akour A; Alshaik F; Alshaer W
    Heliyon; 2023 Jun; 9(6):e17267. PubMed ID: 37408902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.
    Hu S; Zhang Y
    Int J Nanomedicine; 2010 Nov; 5():1039-48. PubMed ID: 21170352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine-chitosan- and arginine-polyethylene glycol-conjugated superparamagnetic nanoparticles: Preparation, cytotoxicity and controlled-release.
    Hussein-Al-Ali SH; Arulselvan P; Fakurazi S; Hussein MZ; Dorniani D
    J Biomater Appl; 2014 Aug; 29(2):186-198. PubMed ID: 24445774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid: a polyphenolic compound potentiates the therapeutic efficacy of cisplatin in human breast cancer cells.
    Shruthi S; Mumbrekar KD; Rao BSS; Shenoy BK
    Toxicol Res (Camb); 2023 Aug; 12(4):544-550. PubMed ID: 37663803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of chitosan-Polyethylene glycol-polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles as carrier system: Drug loading and in vitro drug release study.
    Prabha G; Raj V
    J Biomed Mater Res B Appl Biomater; 2016 May; 104(4):808-16. PubMed ID: 26996397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles.
    Shan F; Liu Y; Jiang H; Tong F
    Int J Nanomedicine; 2017; 12():7613-7625. PubMed ID: 29089759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving gallic acid and quercetin bioavailability by polymeric nanoparticle formulation.
    Patil P; Killedar S
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1656-1663. PubMed ID: 35179095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway.
    Zhang T; Ma L; Wu P; Li W; Li T; Gu R; Dan X; Li Z; Fan X; Xiao Z
    Oncol Rep; 2019 Mar; 41(3):1779-1788. PubMed ID: 30747218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.